Assembly Biosciences (ASMB) Amortization of Deferred Charges (2010 - 2011)
Assembly Biosciences (ASMB) recorded quarterly Amortization of Deferred Charges of $279933.0 in Q3 2011, up 1306.06% quarter-over-quarter from $19909.0 in Q4 2010, and down 70.01% on a YoY basis from $933412.0 in Q3 2010.
Assembly Biosciences (ASMB) Amortization of Deferred Charges (2010 - 2011) Analysis & Trends
Assembly Biosciences' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $279933.0 for Q3 2011.
- In Q3 2011, Amortization of Deferred Charges fell 70.01% year-over-year to $279933.0; the TTM figure through Jun 2012 stood at $279933.0 (changed N/A YoY), while the FY2011 annual figure was $328958.0, down 85.86% from the prior year.
- Amortization of Deferred Charges was $279933.0 for Q3 2011 at Assembly Biosciences, up from $19909.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $933412.0 in Q3 2010 to a low of $19909.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 279,933.00 |
| Sep 30, 2011 | 279,933.00 |
| Dec 31, 2010 | 19,909.00 |
| Dec 31, 2010 | 19,909.00 |
| Sep 30, 2010 | 933,412.00 |
| Sep 30, 2010 | 933,412.00 |